We are a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). We believe that our lead products, the EsoGuard® Esophageal DNA Test […]

We intend to focus on businesses in the media/entertainment/sports industry, including “over-the-top” digital streaming, mobile gaming/interactive entertainment, digital media including advertising/marketing technology, health and wellness/lifestyle, live events/experiential consumer-facing technology, and related industries which can capitalize on our management team’s expertise. Our management team is led by Joseph R. Ianniello, our CEO and chairman, and Marc […]

(Note: This is NOT an IPO. This is an uplift to the NASDAQ from the Toronto Stock Exchange. Our Common Shares are listed and posted for trading on the Toronto Stock Exchange (the “TSX”) under the symbol “VB”. On September 10, 2021, the last trading day before the filing of this preliminary form of Prospectus Supplement, the […]

We intend to focus our search initially on North American and European businesses in the consumer and technology sectors, which complements the expertise of our management team. (Incorporated in the Cayman Islands) Our company will combine the abilities of a diverse and founder-friendly management team and board of directors. We have assembled a team of retail and technology […]

We intend to pursue business combinations with companies in the climate and sustainability spaces (collectively, “Climate and Sustainability”) which facilitate the Circular Economy, progress via the energy transition away from fossil fuels, enhance food chain continuity, recycling and alternative sourcing, as well as mitigate greenhouse gases and reduce plastic waste in the environment. We will […]

Allvue sets a new standard in technology for investment managers in the private capital and credit markets by pairing modern cloud-based software solutions with capabilities across multiple asset classes. Our software solutions serve the entire investment lifecycle and are seamlessly integrated to provide a comprehensive product suite. We serve investment managers of all sizes worldwide, […]

OLAPLEX is an innovative science-enabled and technology-driven beauty company. We are founded on the principle of delivering effective, patent-protected and proven performance in the categories where we compete. We strive to empower our consumers to look as beautiful on the outside as they feel on the inside. We believe every person deserves to have healthy […]

Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region. However, we shall not undertake our initial business combination with any entity with its principal business operations in China (including Hong Kong). (New blank-check company or SPAC incorporated in the British Virgin Islands) Our sponsor, Mr. Hooy […]

We are a commercial-stage medical technology and digital health company focused on developing comprehensive solutions to improve the health and quality of life of people with diabetes. We developed our first commercial product, the POGO Automatic Blood Glucose Monitoring System, or POGO Automatic, to revolutionize the blood glucose testing process for individuals living with diabetes. […]

Note: This is NOT an IPO. Amplitude, Inc., is offering shares of Class A common stock in a direct listing on the NASDAQ, with its stock expected to begin trading on or about Sept. 28, 2021. There are no underwriters. The financial advisors for the direct listing are Morgan Stanley, BofA Securities, Inc., Citigroup Global Markets […]